FIELD: chemistry.
SUBSTANCE: invention relates to medicine and represents anaesthetic composition, which contains neuroactive steroidal anaesthetic, composed with cyclodextrin, where neuroactive steroidal anaesthetic is selected from the group, consisting of alphadolone, alphaxalone and pregnanolone. Cyclodextrin represents (7) sulphobutyl ether of beta-cyclodextrin. Molar ratio of steroidal anaesthetic to cyclodextrin is within the interval from 1:1.6 to 1:2.5, except alphadolone, where it constitutes from 1:2 to 1:2.5. Invention also relates to methods for induction of anaesthesia and sedative effect by means of composition.
EFFECT: low toxicity and reduced content of sulphoalkyl ether of beta-cyclodextrin.
7 cl, 11 ex, 7 tbl, 12 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROACTIVE STEROIDS, COMPOSITIONS AND METHODS OF USING THEM | 2015 |
|
RU2731000C2 |
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2824132C2 |
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2667010C2 |
| NANOSUSPENSION BASED ON ALGINATE-CHITOSAN POLYELECTROLYTE COMPLEX WITH ARTICAINE HYDROCHLORIDE FOR LOCAL ANESTHESIA | 2023 |
|
RU2806363C1 |
| NEUROACTIVE STEROID SOLUTIONS AND METHODS FOR ADMINISTRATION | 2016 |
|
RU2803464C2 |
| EMULSIONS "OIL-IN-WATER" CONTAINING PROPOFOL AND EDETATE | 1995 |
|
RU2147432C1 |
| ETOMIDATE ANALOGUES WITH IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES | 2009 |
|
RU2540116C2 |
| NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS | 2013 |
|
RU2681835C2 |
| FORMULATIONS OF INTRAVENOUS SOLUTIONS OF POSACONAZOLE STABILISED BY SUBSTITUTED BETA-CYCLODEXTRINE | 2011 |
|
RU2575768C2 |
| MEDICINAL PREPARATION CONTAINING LIPOPHILIC INERT GAS | 1998 |
|
RU2204397C2 |
